Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours

S. Bortolussi, J. G. Bakeine, F. Ballarini, P. Bruschi, M. A. Gadan, N. Protti, S. Stella, A. Clerici, C. Ferrari, L. Cansolino, C. Zonta, A. Zonta, R. Nano, S. Altieri

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Lung carcinoma is the leading cause of cancer mortality in the Western countries. Despite the introduction over the last few years of new therapeutic agents, survival from lung cancer has shown no discernible improvement in the last 20 years. For these reasons any efforts to find and validate new effective therapeutic procedures for lung cancer are very timely. The selective boron uptake in the tumour with respect to healthy tissues makes Boron Neutron Capture Therapy a potentially advantageous option in the treatment of tumours that affect whole vital organs, and that are surgically inoperable. To study the possibility of applying BNCT to the treatment of diffuse pulmonary tumours, an animal model for boron uptake measurements in lung metastases was developed. Both healthy and tumour-bearing rats were infused with Boronophenylalanine (BPA) and sacrificed at different time intervals after drug administration. The lungs were extracted, and prepared for boron analysis by neutron autoradiography and α-spectroscopy. The boron concentrations in tumour and normal lung were plotted as a function of the time elapsed after BPA administration. The concentration in tumour is almost constant within the error bars for all the time intervals of the experiment (1-8. h), while the curve in normal lung decreases after 4. h from BPA infusion. At 4. h, the ratio of boron concentration in tumour to boron concentration in healthy lung is higher than 3, and it stays above this level up to 8. h. Also the images of boron distribution in the samples, obtained by neutron autoradiography, show a selective absorption in the metastases.

Original languageEnglish
Pages (from-to)394-398
Number of pages5
JournalApplied Radiation and Isotopes
Volume69
Issue number2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

lungs
rats
therapy
boron
tumors
neutrons
cancer
autoradiography
metastasis
intervals
animal models
mortality
guy wires
organs
drugs
causes
curves
spectroscopy

Keywords

  • BNCT
  • Boron bio-distribution
  • Boron uptake
  • BPA
  • Lung tumours
  • Neutron autoradiography

ASJC Scopus subject areas

  • Radiation

Cite this

Bortolussi, S., Bakeine, J. G., Ballarini, F., Bruschi, P., Gadan, M. A., Protti, N., ... Altieri, S. (2011). Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours. Applied Radiation and Isotopes, 69(2), 394-398. https://doi.org/10.1016/j.apradiso.2010.11.018

Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours. / Bortolussi, S.; Bakeine, J. G.; Ballarini, F.; Bruschi, P.; Gadan, M. A.; Protti, N.; Stella, S.; Clerici, A.; Ferrari, C.; Cansolino, L.; Zonta, C.; Zonta, A.; Nano, R.; Altieri, S.

In: Applied Radiation and Isotopes, Vol. 69, No. 2, 02.2011, p. 394-398.

Research output: Contribution to journalArticle

Bortolussi, S, Bakeine, JG, Ballarini, F, Bruschi, P, Gadan, MA, Protti, N, Stella, S, Clerici, A, Ferrari, C, Cansolino, L, Zonta, C, Zonta, A, Nano, R & Altieri, S 2011, 'Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours', Applied Radiation and Isotopes, vol. 69, no. 2, pp. 394-398. https://doi.org/10.1016/j.apradiso.2010.11.018
Bortolussi, S. ; Bakeine, J. G. ; Ballarini, F. ; Bruschi, P. ; Gadan, M. A. ; Protti, N. ; Stella, S. ; Clerici, A. ; Ferrari, C. ; Cansolino, L. ; Zonta, C. ; Zonta, A. ; Nano, R. ; Altieri, S. / Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours. In: Applied Radiation and Isotopes. 2011 ; Vol. 69, No. 2. pp. 394-398.
@article{e1da65f3b1344ce6b4c89dfa3e8add30,
title = "Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours",
abstract = "Lung carcinoma is the leading cause of cancer mortality in the Western countries. Despite the introduction over the last few years of new therapeutic agents, survival from lung cancer has shown no discernible improvement in the last 20 years. For these reasons any efforts to find and validate new effective therapeutic procedures for lung cancer are very timely. The selective boron uptake in the tumour with respect to healthy tissues makes Boron Neutron Capture Therapy a potentially advantageous option in the treatment of tumours that affect whole vital organs, and that are surgically inoperable. To study the possibility of applying BNCT to the treatment of diffuse pulmonary tumours, an animal model for boron uptake measurements in lung metastases was developed. Both healthy and tumour-bearing rats were infused with Boronophenylalanine (BPA) and sacrificed at different time intervals after drug administration. The lungs were extracted, and prepared for boron analysis by neutron autoradiography and α-spectroscopy. The boron concentrations in tumour and normal lung were plotted as a function of the time elapsed after BPA administration. The concentration in tumour is almost constant within the error bars for all the time intervals of the experiment (1-8. h), while the curve in normal lung decreases after 4. h from BPA infusion. At 4. h, the ratio of boron concentration in tumour to boron concentration in healthy lung is higher than 3, and it stays above this level up to 8. h. Also the images of boron distribution in the samples, obtained by neutron autoradiography, show a selective absorption in the metastases.",
keywords = "BNCT, Boron bio-distribution, Boron uptake, BPA, Lung tumours, Neutron autoradiography",
author = "S. Bortolussi and Bakeine, {J. G.} and F. Ballarini and P. Bruschi and Gadan, {M. A.} and N. Protti and S. Stella and A. Clerici and C. Ferrari and L. Cansolino and C. Zonta and A. Zonta and R. Nano and S. Altieri",
year = "2011",
month = "2",
doi = "10.1016/j.apradiso.2010.11.018",
language = "English",
volume = "69",
pages = "394--398",
journal = "Applied Radiation and Isotopes",
issn = "0969-8043",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours

AU - Bortolussi, S.

AU - Bakeine, J. G.

AU - Ballarini, F.

AU - Bruschi, P.

AU - Gadan, M. A.

AU - Protti, N.

AU - Stella, S.

AU - Clerici, A.

AU - Ferrari, C.

AU - Cansolino, L.

AU - Zonta, C.

AU - Zonta, A.

AU - Nano, R.

AU - Altieri, S.

PY - 2011/2

Y1 - 2011/2

N2 - Lung carcinoma is the leading cause of cancer mortality in the Western countries. Despite the introduction over the last few years of new therapeutic agents, survival from lung cancer has shown no discernible improvement in the last 20 years. For these reasons any efforts to find and validate new effective therapeutic procedures for lung cancer are very timely. The selective boron uptake in the tumour with respect to healthy tissues makes Boron Neutron Capture Therapy a potentially advantageous option in the treatment of tumours that affect whole vital organs, and that are surgically inoperable. To study the possibility of applying BNCT to the treatment of diffuse pulmonary tumours, an animal model for boron uptake measurements in lung metastases was developed. Both healthy and tumour-bearing rats were infused with Boronophenylalanine (BPA) and sacrificed at different time intervals after drug administration. The lungs were extracted, and prepared for boron analysis by neutron autoradiography and α-spectroscopy. The boron concentrations in tumour and normal lung were plotted as a function of the time elapsed after BPA administration. The concentration in tumour is almost constant within the error bars for all the time intervals of the experiment (1-8. h), while the curve in normal lung decreases after 4. h from BPA infusion. At 4. h, the ratio of boron concentration in tumour to boron concentration in healthy lung is higher than 3, and it stays above this level up to 8. h. Also the images of boron distribution in the samples, obtained by neutron autoradiography, show a selective absorption in the metastases.

AB - Lung carcinoma is the leading cause of cancer mortality in the Western countries. Despite the introduction over the last few years of new therapeutic agents, survival from lung cancer has shown no discernible improvement in the last 20 years. For these reasons any efforts to find and validate new effective therapeutic procedures for lung cancer are very timely. The selective boron uptake in the tumour with respect to healthy tissues makes Boron Neutron Capture Therapy a potentially advantageous option in the treatment of tumours that affect whole vital organs, and that are surgically inoperable. To study the possibility of applying BNCT to the treatment of diffuse pulmonary tumours, an animal model for boron uptake measurements in lung metastases was developed. Both healthy and tumour-bearing rats were infused with Boronophenylalanine (BPA) and sacrificed at different time intervals after drug administration. The lungs were extracted, and prepared for boron analysis by neutron autoradiography and α-spectroscopy. The boron concentrations in tumour and normal lung were plotted as a function of the time elapsed after BPA administration. The concentration in tumour is almost constant within the error bars for all the time intervals of the experiment (1-8. h), while the curve in normal lung decreases after 4. h from BPA infusion. At 4. h, the ratio of boron concentration in tumour to boron concentration in healthy lung is higher than 3, and it stays above this level up to 8. h. Also the images of boron distribution in the samples, obtained by neutron autoradiography, show a selective absorption in the metastases.

KW - BNCT

KW - Boron bio-distribution

KW - Boron uptake

KW - BPA

KW - Lung tumours

KW - Neutron autoradiography

UR - http://www.scopus.com/inward/record.url?scp=78650309644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650309644&partnerID=8YFLogxK

U2 - 10.1016/j.apradiso.2010.11.018

DO - 10.1016/j.apradiso.2010.11.018

M3 - Article

C2 - 21145752

AN - SCOPUS:78650309644

VL - 69

SP - 394

EP - 398

JO - Applied Radiation and Isotopes

JF - Applied Radiation and Isotopes

SN - 0969-8043

IS - 2

ER -